Resisting resistance to cancer immunotherapy

Resisting resistance to cancer immunotherapy

THORACIC CANCER

Saved in:

Bibliographic Details
Main Authors:	RAGHAV SUNDAR, Lam, W.S.-T., Wang, L.Z., Roudi, R., Yong, W.-P., Syn, N.L.
Other Authors:	CANCER SCIENCE INSTITUTE OF SINGAPORE
Published:	WILEY 2021
Subjects:	Science & Technology Life Sciences & Biomedicine Oncology Respiratory System
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/206998
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items

Resisting resistance to cancer immunotherapy
by: Lam, W.S.-T., et al.
Published: (2021)

Lung Cancer in Singapore
by: Ang, Yvonne LE, et al.
Published: (2022)

High efficacy of BAY 1187982, an FGFR2-ADC, in overcoming drug resistance in a diffuse type gastric cancer patient-derived xenograft model with acquired resistance to pan-FGFR inhibitor AZD4547
by: Lau, Wen Min, et al.
Published: (2019)

Anti-CD137 Cancer Immunotherapy Suppresses Tumor Growth-Letter
by: Dharmadhikari, Bhushan, et al.
Published: (2023)

Factors Predictive of Primary Resistance to Immune Checkpoint Inhibitors in Asian Patients with Advanced NSCLC
by: Huang, Y, et al.
Published: (2023)

Correction to: 33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2018)
by: Berry, Sneha, et al.
Published: (2021)

A segregated-team model to maintain cancer care during the COVID-19 outbreak at an academic center in Singapore
by: Ngoi, N, et al.
Published: (2020)

Mammography screening is associated with more favorable breast cancer tumor characteristics and better overall survival: Case-only analysis of 3,739 Asian breast cancer patients.
by: Hartman, Mikael, et al.
Published: (2023)

Chua et al. Cost-Effectiveness Analysis of HPV Extended versus Partial Genotyping for Cervical Cancer Screening in Singapore. <i>Cancers</i> (vol <i>15</i>, 1812, 2023)
by: Chua, Brandon, et al.
Published: (2023)

Association Between SLC16A5 Genetic Variation and Cisplatin-Induced Ototoxic Effects in Adult Patients With Testicular Cancer
by: Drogemoller, Britt I, et al.
Published: (2022)

COVID-19 Severity and Waning Immunity After up to 4 mRNA Vaccine Doses in 73 608 Patients With Cancer and 621 475 Matched Controls in Singapore A Nationwide Cohort Study
by: Tan, Wei Chong, et al.
Published: (2023)

Applying the ASCO and ESMO Value Frameworks to nasopharyngeal cancer treatments: Is adding induction chemotherapy or adjuvant chemotherapy to concurrent chemoradiotherapy worthwhile?
by: Tan, Teng Hwee, et al.
Published: (2023)

Applying the ASCO and European Society for Medical Oncology Value Frameworks to Nasopharyngeal Cancer Treatments: Is Adding Induction Chemotherapy or Adjuvant Chemotherapy to Concurrent Chemoradiotherapy Worthwhile?
by: Tan, Teng Hwee, et al.
Published: (2022)

NSCLC PATIENTS WITH BOTH WILDTYPE EGFR AND HIGH CD151 EXPRESSION HAVE POORER DISEASE OUTCOME
by: Wong, Amanda, et al.
Published: (2019)

Prone Positioning of Patients during Venovenous Extracorporeal Membrane Oxygenation
by: Shekar, Kiran, et al.
Published: (2021)

The long and short non-coding RNAs modulating EZH2 signaling in cancer (vol 15, 18, 2022)
by: Mirzaei, Sepideh, et al.
Published: (2023)

Correction: The long and short non-coding RNAs modulating EZH2 signaling in cancer (vol 15, 18, 2022)
by: Mirzaei, Sepideh, et al.
Published: (2023)

The 4th European Society for Medical Oncology Asia Congress: bridging ultimate cancer care with real-world practice for the Asian practitioner in gynecological cancers
by: Ngoi, Natalie YL, et al.
Published: (2021)

Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group
by: Moreau, Philippe, et al.
Published: (2021)

Lineage-specific RUNX2 super-enhancer activates MYC via a chromosomal translocation and promotes the BPDCN
by: Kubota, Sho, et al.
Published: (2019)

Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastases (vol 18, 1198, 2018)
by: Tan, Wan-Ling, et al.
Published: (2022)

Pharmacogenomic prediction of immune-related adverse events from immune checkpoint inhibitors among Asian patients
by: Huang, Yiqing, et al.
Published: (2022)

Dendritic cell therapy with CD137L-DC-EBV-VAX in locally recurrent or metastatic nasopharyngeal carcinoma (NPC).
by: Walsh, Robert John, et al.
Published: (2023)

ZMYND10, an epigenetically regulated tumor suppressor, exerts tumor-suppressive functions via miR145-5p/NEDD9 axis in breast cancer (vol 11, 184, 2019)
by: Wang, Yan, et al.
Published: (2023)

Characterization of MET-N375S as an Activating Mutation in Squamous Cell Carcinoma of the Lung
by: Kong, Li Ren, et al.
Published: (2024)

Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemia (vol 30, pg 1672, 2016)
by: Madan, V, et al.
Published: (2023)

Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemia (vol 30, pg 1672, 2016)
by: Madan, V, et al.
Published: (2022)

The tumor suppressor Zinc finger protein 471 suppresses breast cancer growth and metastasis through inhibiting AKT and Wnt/beta-catenin signaling (vol 12, 173, 2020)
by: Tao, Chunfang, et al.
Published: (2023)

Utilizing distinct CAR and TCR signaling to generate enhanced cellular immunotherapy
by: Gascoigne, Nicholas RJ, et al.
Published: (2023)

Correction: The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms (vol 36, pg 1720, 2022)
by: Alaggio, Rita, et al.
Published: (2023)

Tumoral STING is required for effective anticancer immunity
by: Suter, Manuel Adrian, et al.
Published: (2023)

Myeloma-specific superenhancers affect genes of biological and clinical relevance in myeloma
by: Jia, Yunlu, et al.
Published: (2021)

A balancing act-the role of opioid-sparing anesthesia in enhancing recovery after thoracic surgery
by: Tam, John Kit Chung
Published: (2022)

A Phase I, First-in-Human Study of PRL3-zumab in Advanced, Refractory Solid Tumors and Hematological Malignancies
by: Chee, Cheng E, et al.
Published: (2023)

Combining DNA damaging therapeutics with immunotherapy: more haste, less speed
by: Brown, Jessica S, et al.
Published: (2022)

Risk Factors for Immune-Related Adverse Events from Anti-PD-1/PD-L1 Treatment in an Asian Cohort of NSCLC Patients
by: Huang, Y, et al.
Published: (2023)

Large expert-curated database for benchmarking document similarity detection in biomedical literature search
by: Brown, Peter, et al.
Published: (2021)

A Unique CD27-IgD(-) B Cell Population in the Sputum of Severe Eosinophilic Asthma Associated with Airway Autoimmunity
by: Tan, Nadia Suray, et al.
Published: (2023)

GM2-activator protein: A new biomarker for lung cancer
by: Potprommanee,L., et al.
Published: (2015)

Rethinking COVID-19 'pneumonia' - is this primarily a vaso-occlusive disease, and can early anticoagulation save the ventilator famine?
by: Low, Ting-Ting, et al.
Published: (2021)